Skip to content

H2020FP7HORIZON

Institut Curie

Country
FRFrance
Defence projects
0
Projects, all programmes
185
As coordinator
98
EU contribution (CORDIS)
EUR 110,744,093
Active
2008 to 2026

Projects

185 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ARTiDeAutoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)HORIZON2023ParticipantEUR 225,000
CERTAINTYA CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNTHORIZON2023ParticipantEUR 435,643
HOTIMAGEHOst-Transposon Interactions in the MAle GErmlineHORIZON2023ParticipantEUR 832,500
RBP-ReguNetDeconstructing and Rewiring RNA-RBP regulatory networksHORIZON2023ParticipantEUR 282,694
EVCACentre for Excellence in Diagnostic and Advanced Therapeutics based on Extracellular VesiclesHORIZON2022ParticipantEUR 360,338
TargetBRCATo develop a new targeted therapy for the treatment of naive and PARP inhibitor-resistant BRCA1/2-mutated tumorsHORIZON2022CoordinatorEUR 150,000
CellinfoQuantification of information flow in a cell signaling pathwayH20202022CoordinatorEUR 184,708
RELEVIUMImproving quality of life of advanced pancreatic cancer patients through an AI-guided multimodal intervention, combining pain and cachexia management, nutrition, and physical activityHORIZON2022ParticipantEUR 200,000
GlioSurgRole of astrogliosis in the recurrence of brain tumors after microsurgical resectionHORIZON2022CoordinatorEUR 209,687
PROTECT-trialProton versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyH20202021ParticipantEUR 5,075
Fas_Life-DeathA Biophysical Investigation of the Duality in Fas ReceptorH20202021CoordinatorEUR 184,708
ChromTraceTracing epigenetic evolution of triple-negative breast cancer towards chemo-resistanceH20202021Third partyNot stated
MIMICDeciphering how microbiota modulate anti-tumor immune responses in checkpoint therapyH20202020CoordinatorEUR 184,708
IMPEDINTEGRATED MICROFLUIDIC PLATFORM FOR PROTEOMIC AND GENETIC EXOSOME DETECTIONH20202020CoordinatorEUR 225,381
GrowthDevStabilityCharacterization of the developmental mechanisms ensuring a robust symmetrical growth in the bilateral model organism Drosophila melanogasterH20202020CoordinatorEUR 184,708
PROSTATORReliable urinary test for the diagnosis of prostate cancerH20202020CoordinatorEUR 150,000
KILL-OR-DIFFERENTIATUsing cell-cell interactions to unlock new cancer treatments: Forcing neural crest tumors back onto the developmental pathH20202020Third partyNot stated
EuReCaInstitut Curie EuReCa PhD ProgrammeH20202020CoordinatorEUR 3,173,040
oncNGSNGS diagnostics in 21st century oncology: the best, for all, at all timesH20202020ParticipantEUR 300,112
MAITTissue repair functions of MAIT cells: integrating thymic pre-commitment and peripheral signalsH20202020CoordinatorEUR 2,499,500

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.